Jericho Financial LLP Decreases Position in Chemed Corporation $CHE

Jericho Financial LLP trimmed its stake in shares of Chemed Corporation (NYSE:CHE) by 82.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,260 shares of the company’s stock after selling 5,786 shares during the period. Jericho Financial LLP’s holdings in Chemed were worth $539,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its position in shares of Chemed by 122.7% in the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after purchasing an additional 275,423 shares during the period. William Blair Investment Management LLC boosted its position in shares of Chemed by 13.6% during the third quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock worth $172,435,000 after acquiring an additional 46,038 shares during the last quarter. Epoch Investment Partners Inc. raised its stake in Chemed by 29.4% during the third quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock valued at $137,579,000 after purchasing an additional 69,878 shares in the last quarter. TD Asset Management Inc raised its stake in Chemed by 23.1% during the third quarter. TD Asset Management Inc now owns 301,831 shares of the company’s stock valued at $135,142,000 after purchasing an additional 56,546 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Chemed by 5.6% during the third quarter. Dimensional Fund Advisors LP now owns 240,180 shares of the company’s stock valued at $107,542,000 after purchasing an additional 12,810 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CHE. Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Oppenheimer dropped their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $498.00.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.29% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $388.50 on Wednesday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $604.91. The company’s fifty day moving average price is $418.80 and its 200 day moving average price is $431.73. The stock has a market capitalization of $5.35 billion, a P/E ratio of 21.15, a P/E/G ratio of 1.51 and a beta of 0.49.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.02 by ($0.60). The business had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the firm earned $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Sell-side analysts predict that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were given a $0.60 dividend. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio is presently 13.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.